Corbus Pharmaceuticals reports no neuropsychiatric events in CRB-913 trial, advancing to multiple ascending dose phase. Study completion projected for Q3 2025. Corbus Pharmaceuticals Holdings Inc. has ...
Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Listening to sad music can make you feel connected and ...
A new study published in the journal Cognitive Science helps explain why people often find themselves drawn to sad art forms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback